Ventas Stock Price, News & Analysis

Ventas, Inc. (NYSE: VTR) has received a Stable outlook revision from Fitch Ratings, affirming its BBB+ credit rating. The upgrade is attributed to positive trends in Ventas’s senior housing operating portfolio, which is witnessing gains in rent growth and occupancy. Fitch anticipates a robust recovery driven by an increasing population aged 80+. Ventas benefits from a diversified portfolio, with around 30% in high-quality medical office buildings and life science properties. The company also enjoys strong liquidity with minimal debt due this year.

Ventas, Inc. (NYSE: VTR) has appointed Pamela Boneham as a Senior Strategic Advisor to its Ventas Investment Management (VIM) Platform. Boneham will leverage her extensive experience in commercial real estate to guide VIM, which manages over $5 billion in assets, focusing on high-quality life science and healthcare real estate investments. Ventas aims to attract global private capital and enhance its investment capacity while capitalizing on demographic trends in healthcare real estate.

Ventas, Inc. (NYSE: VTR) will present at the Nareit REITweek 2022 Investor Conference on June 8, 2022 at 2:00 p.m. ET. The presentation will be available via webcast on the company’s website.

Accompanying materials, including forward-looking information, will be posted on June 7, 2022. Ventas operates a diverse portfolio of over 1,200 healthcare and real estate properties across the U.S., Canada, and the U.K., targeting senior living and medical facilities, reflecting its strong market position and sustainable growth strategy.

Ventas, Inc. (NYSE: VTR) has declared a quarterly dividend of $0.45 per common share. This dividend will be payable on July 14, 2022, to stockholders of record as of the close of business on July 1, 2022. Ventas operates in the healthcare and real estate sectors, owning over 1,200 properties across the US, Canada, and the UK, driven by demographic demand from an aging population. The company focuses on senior living, life sciences, and healthcare real estate, supported by a long-term growth strategy and strong financial performance.

Ventas, Inc. (NYSE: VTR) has been recognized as one of the 100 best corporate citizens for the third consecutive year by 3BL Media, ranking #53 overall, improving from #67 last year. The company ranked #3 in real estate and #1 among healthcare REITs. This recognition highlights Ventas's commitment to environmental, social, and governance (ESG) practices, with the 2022 ranking considering 155 ESG factors. Ventas operates over 1,200 properties across the U.S., Canada, and the U.K., focusing on senior living, life sciences, and healthcare real estate.

Ventas, Inc. (NYSE: VTR) has received a stable outlook from S&P Global Ratings after affirming its BBB+ credit rating. The revision acknowledges Ventas’s performance recovery in senior housing, predicting continued improvement in credit metrics. The company reported a same-store SHOP occupancy of 83%, a 420 basis point increase since early 2021. Ventas's balance sheet has been strengthened by fixed-rate debt and a robust liquidity position of $2.2 billion available. Positive demographic trends are expected to bolster future occupancy recovery.

Ventas, Inc. (NYSE: VTR) announced participation in investor meetings at the BMO 2022 Real Estate Summit on May 12, 2022. Management will present and share written materials that may include forward-looking information, available on the Company’s website on the same date. Ventas operates over 1,200 properties across the U.S., Canada, and the UK, focusing on healthcare and real estate driven by the aging population. As an S&P 500 company, it follows a successful long-term strategy emphasizing property diversification, financial strength, and ESG commitments.

Ventas reported Q1 2022 net income of $0.10 per share and normalized FFO of $0.79 per share, benefiting from $33 million in HHS Grants. The company's same-store cash NOI grew 5.8%, with the SHOP segment achieving 14.2% growth driven by nearly 10% revenue growth. Year-to-date, Ventas closed or committed to approximately $500 million in new investments. For Q2 2022, guidance suggests net income per share between ($0.03) and $0.01, and normalized FFO of $0.69 to $0.73. The company expects further improvement in the SHOP segment amidst inflationary pressures.